530125 — Samrat Pharmachem Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.08bn
- IN₹1.17bn
- IN₹2.86bn
- 70
- 55
- 38
- 57
Annual cashflow statement for Samrat Pharmachem, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | C2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 73.4 | 236 | 225 | 25.2 | 98.9 |
| Depreciation | |||||
| Non-Cash Items | 12.1 | 5.92 | 10.1 | -6.19 | -0.081 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -42.1 | -73.1 | -336 | 68.6 | -206 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 48.3 | 175 | -94.4 | 94.1 | -101 |
| Capital Expenditures | -27.3 | -12.8 | -13.6 | -6.67 | -5.07 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -1.95 | 2.13 | -16.5 | 2.61 | 5.02 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -29.2 | -10.6 | -30.1 | -4.06 | -0.049 |
| Financing Cash Flow Items | -12.7 | -6.75 | -12.3 | -6.87 | -6.74 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -18.9 | -19.5 | 96 | -112 | 4.77 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.212 | 145 | -28.4 | -21.9 | -96.2 |